Notes / Company

Mankind Pharma Ltd.

MANKIND BSE 543904 ISIN INE634S01028 Pharmaceuticals

Fundamentals

Market cap: ₹1.02 lakh cr
P/E: 53.16×
ROE: 13.89%
Debt / equity: 0.58
52-week range: 1909.70 — 2716.50

Research on Tijori Finance

Company snapshot

Mankind Pharma Ltd.

Pharmaceuticals

₹1.05 L cr

P/E 54.65×

Latest quarter · Mar 2026

Sales₹3,443 cr

Net profit₹556 cr

Op. margin+27.0%

EPS₹13.43

Strength & growth

Debt / equity0.58×

Current ratio1.23×

The timeline — 1 note on Mankind Pharma Ltd.

May 2026

26 May 26 · 5:04 PM IST Brief

Brief · Earnings · Mega cap

Mankind guides for double-digit growth, plans ₹2,500 cr debt repayment

Management targets FY27 EBITDA margins of 25.5-26.5% and will focus on profitability in GLP-1 over market share.

Verify on exchange BSE filings for MANKIND NSE filings for MANKIND Tijori Finance company page